tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Financial Statements

Compare
605 Followers

Pyxis Oncology Financial Overview

Pyxis Oncology's market cap is currently $87.34M. The company's EPS TTM is $-0.28; its P/E ratio is -0.90; Pyxis Oncology is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 13.86M$ 16.15M$ 0.00$ 0.00$ 0.00
Gross Profit$ 11.47M$ 15.67M$ 0.00$ 0.00$ 0.00
Operating Income$ -84.42M$ -89.46M$ -82.20M$ -123.48M$ -69.72M
EBITDA$ -79.91M$ -65.51M$ -80.27M$ -122.77M$ -69.07M
Net Income$ -79.62M$ -77.33M$ -73.79M$ -120.72M$ -75.97M
Balance Sheet
Cash & Short-Term Investments$ 66.86M$ 126.93M$ 119.30M$ 179.29M$ 274.74M
Total Assets$ 91.52M$ 157.18M$ 173.73M$ 211.38M$ 280.02M
Total Debt$ 18.67M$ 20.20M$ 21.33M$ 18.92M$ 165.00K
Net Debt$ 3.25M$ 727.00K$ 11.67M$ -160.37M$ -274.57M
Total Liabilities$ 38.11M$ 36.43M$ 48.02M$ 50.55M$ 18.71M
Stockholders' Equity$ 53.41M$ 120.75M$ 125.70M$ 160.82M$ 261.31M
Cash Flow
Free Cash Flow$ -63.51M$ -57.91M$ -77.44M$ -95.73M$ -35.87M
Operating Cash Flow$ -63.50M$ -57.67M$ -70.71M$ -89.33M$ -35.33M
Investing Cash Flow$ 58.86M$ 8.15M$ -104.85M$ -6.40M$ -590.00K
Financing Cash Flow$ 594.00K$ 59.33M$ 5.93M$ 183.00K$ 304.04M
Currency in USD

Pyxis Oncology Earnings and Revenue History

Pyxis Oncology Debt to Assets

Pyxis Oncology Cash Flow

Pyxis Oncology Forecast EPS vs Actual EPS